Projects per year
Fingerprint
Dive into the research topics where Gerard Lozanski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma
Gurcan, M. N. (CoPI) & Lozanski, G. (CoPI)
05/1/09 → 05/31/19
Project: Research
-
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclax-resistant chronic lymphocytic leukemia
Ravikrishnan, J., Diaz-Rohena, D. Y., Muhowski, E., Mo, X., Lai, T. H., Misra, S., Williams, C. D., Sanchez, J. R., Mitchell, A., Satpati, S., Perry, E., Kaufman, T., Liu, C., Lozanski, A., Lozanski, G., Rogers, K. A., Kittai, A. S., Bhat, S. A., Collins, M. C. & Davids, M. S. & 11 others, , Jan 2025, In: Haematologica. 110, 1, p. 78-91 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study
Luskin, M. R., Yin, J., Lozanski, G., Curran, E., Malnassy, G., Mrózek, K., Bloomfield, C. D., Cataland, S. R., Fulton, N., Kolitz, J., Laplant, B., Kour, O., Powell, B. L., Vij, R., Wang, E. S., Grinblatt, D., Stone, R. M., Uy, G. L., Larson, R. A. & Stock, W., Feb 15 2025, In: Cancer. 131, 4, e35750.Research output: Contribution to journal › Article › peer-review
Open Access -
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial (Nature Medicine, (2022), 28, 10, (2155-2161), 10.1038/s41591-022-01962-5)
LCMC study investigators, Jan 2024, In: Nature Medicine. 30, 1, p. 303 1 p.Research output: Contribution to journal › Comment/debate
Open Access4 Scopus citations -
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL
Woyach, J. A., Perez Burbano, G., Ruppert, A. S., Miller, C., Heerema, N. A., Zhao, W., Wall, A., Ding, W., Bartlett, N. L., Brander, D. M., Barr, P. M., Rogers, K. A., Parikh, S. A., Stephens, D. M., Brown, J. R., Lozanski, G., Blachly, J., Nattam, S., Larson, R. A. & Erba, H. & 12 others, , Apr 18 2024, In: Blood. 143, 16, p. 1616-1627 12 p.Research output: Contribution to journal › Article › peer-review
21 Scopus citations -
Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms
Grever, M., Andritsos, L., Anghelina, M., Arons, E., Banerji, V., Barrientos, J., Bhat, S. A., Blachly, J., Broccoli, A., Call, T., Dearden, C., Dietrich, S., Else, M., Epperla, N., Fagarasanu, A., Falini, B., Forconi, F., Gozzetti, A., Hampel, P. & Hermel, D. J. & 25 others, , Jul 2024, In: Leukemia. 38, 7, p. 1642-1644 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access7 Scopus citations